A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

BACKGROUND: High-volume physical activity (PA) is associated with a higher prevalence of subclinical coronary artery disease ...

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

Controversies in the Treatment of Ischemia-Reperfusion Injury, ” will focus on past and current strategies for reducing the myocardial damage caused by IRI following percutaneous coronary intervention ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...